ADMA Biologics, Inc. (ADMA)
13.56
-0.06
(-0.48%)
USD |
NASDAQ |
Nov 18, 16:00
13.50
-0.06
(-0.48%)
After-Hours: 20:00
ADMA Biologics Price : 13.56 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 13.34 | 13.66 | 13.12 | 13.63 | 2.948M |
| Nov 16, 2026 | 13.72 | 14.07 | 13.46 | 13.47 | 3.051M |
| Nov 13, 2026 | 13.29 | 14.02 | 13.07 | 13.68 | 4.160M |
| Nov 12, 2026 | 13.23 | 13.52 | 13.04 | 13.24 | 3.092M |
| Nov 11, 2026 | 12.71 | 13.28 | 12.60 | 13.19 | 2.565M |
| Nov 10, 2026 | 12.80 | 12.95 | 12.55 | 12.67 | 3.312M |
| Nov 09, 2026 | 12.90 | 13.06 | 12.48 | 12.79 | 3.367M |
| Nov 06, 2026 | 12.88 | 13.20 | 12.52 | 12.73 | 4.648M |
| Nov 05, 2026 | 12.01 | 13.77 | 11.90 | 13.21 | 15.00M |
| Nov 04, 2026 | 11.49 | 11.49 | 10.25 | 10.48 | 13.39M |
| Nov 03, 2026 | 11.09 | 11.44 | 10.70 | 11.11 | 5.056M |
| Nov 02, 2026 | 11.42 | 11.59 | 11.05 | 11.06 | 2.890M |
| Oct 30, 2026 | 11.85 | 11.90 | 11.36 | 11.41 | 2.461M |
| Oct 29, 2026 | 11.37 | 11.77 | 11.34 | 11.75 | 2.745M |
| Oct 28, 2026 | 11.04 | 11.30 | 11.01 | 11.28 | 2.665M |
| Oct 27, 2026 | 11.02 | 11.19 | 10.90 | 11.17 | 2.219M |
| Oct 26, 2026 | 10.73 | 11.12 | 10.70 | 11.06 | 2.027M |
| Oct 23, 2026 | 10.88 | 10.90 | 10.57 | 10.68 | 1.741M |
| Oct 22, 2026 | 11.01 | 11.10 | 10.80 | 10.95 | 3.552M |
| Oct 21, 2026 | 11.17 | 11.28 | 10.92 | 11.01 | 2.006M |
| Oct 20, 2026 | 11.12 | 11.32 | 11.03 | 11.23 | 2.897M |
| Oct 19, 2026 | 10.66 | 11.14 | 10.66 | 11.07 | 2.874M |
| Oct 16, 2026 | 10.73 | 10.87 | 10.60 | 10.68 | 3.074M |
| Oct 15, 2026 | 10.60 | 10.91 | 10.48 | 10.73 | 2.772M |
| Oct 14, 2026 | 10.31 | 10.60 | 10.24 | 10.34 | 2.876M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.84 |
| BioMarin Pharmaceutical, Inc. | 61.40 |
| Nektar Therapeutics | 34.45 |
| Rhythm Pharmaceuticals, Inc. | 119.19 |
| Arcutis Biotherapeutics, Inc. | 27.60 |
Price Related Metrics
| PE Ratio | 17.47 |
| PS Ratio | 6.140 |
| Price to Book Value | 6.892 |
| Price to Free Cash Flow | 24.04 |
| Earnings Yield | 5.72% |
| Market Cap | 3.022B |
| Operating PE Ratio | 13.67 |
| Normalized PE Ratio | 17.47 |